Skip to main navigation
REGENXBIO_Logo-RGB REGENXBIO_Logo-RGB
Corporate Menu
  • About
    • Mission & Values
    • Management Team
    • Board of Directors
  • Nav Technology
  • Therapeutic Programs
    • RGX-314
    • RGX-202
    • RGX-121
    • RGX-111
    • RGX-181
    • RGX-381
  • Patients and Families
    • Gene Therapy
    • Wet AMD
    • DMD
    • MPS II
    • MPS I
    • CLN2
    • Expanded Access
  • Partners & Licensees
    • Partners & Licensees Pipeline
  • Media
    • Press Releases
    • Presentations & Publications
  • Investors
    • Stock Information
    • Recent News
    • SEC Filings
    • Corporate Governance
    • Shareholder Services
  • Join Us

Investors

News & Events

Investor Relations
  • Stock Information
  • News & Events
  • SEC Filings
  • Corporate Governance
  • Shareholder Services
Investor Relations
  • News & Events
    • Stock Information
    • News & Events
    • SEC Filings
    • Corporate Governance
    • Shareholder Services

News & Events

01/11/21
REGENXBIO to Present at the 39th Annual J.P. Morgan Healthcare Conference
01/08/21
REGENXBIO Announces Pricing Of Public Offering Of Common Stock
01/06/21
REGENXBIO Announces Proposed Public Offering Of Common Stock
01/05/21
REGENXBIO Announces Update on RGX-314 and Pivotal Program for the Treatment of Wet AMD and New Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Event Calendar

Webcast

Q4 and Full-Year 2020 REGENXBIO Inc. Earnings Conference Call
Mar 1, 2021 | 4:30 PM EST

Webcast

Raymond James 42nd Annual Institutional Investors Conference
Mar 3, 2021 | 10:50 AM EST
Jan 14, 2021 | 11:40 AM EST
39th Annual J.P. Morgan Healthcare Conference
SIGN UP

Receive updates to stay connected on REGENXBIO programs and our commitment to patients.

Subscribe
Contact Us

9600 Blackwell Road, Suite 210, Rockville, MD 20850
240.552.8181

Contact Us Menu
General Info | Patient Advocacy | Partners | Investors | Media
Follow Us
REGENXBIO_Logo-RGB

©2021 REGENXBIO Inc. "NAV®" is a registered trademark of REGENXBIO Inc. All rights reserved.

Footer
Privacy Policy | Terms and Conditions